Biotechs broke out in a big way this week, rewarding some pretty patient investors amid exciting news for the sector surrounding new cancer treatments. Our call of the day says these stocks could be leaders for the rest of the year.
Biotechs broke out in a big way this week, rewarding some pretty patient investors amid exciting news for the sector surrounding new cancer treatments. Our call of the day says these stocks could be leaders for the rest of the year.